RxDoctor Payments Data

William Hiesinger, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Palo Alto, CANPI 1093913667

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,300 of the $1,905 with a category attached, or 68.2%. Abbott accounts for 87.0% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $1,516 and has fallen 95.3% since, to $71 in 2025. That places this record below the midpoint for thoracic surgery (cardiothoracic vascular surgery) clinicians in CA, where the typical reported total is $4,430.

$1,905in general payments, 2019–2025

Across 11 payments — averaging $173.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Paragonix Technologies, Inc.$122
  • Abiomed$71
  • Livanova USA, Inc.$54
$813,443in research payments, 2019–2025

Across 172 payments — averaging $4729.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Edwards Lifesciences$544K
  • Abbott$150K
  • Medtronic$119K

What the payments were for

  • Consulting fees$1,30068%
  • Food & beverage$60532%

General payments by program year

19
20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott8$1,658
Paragonix Technologies, Inc.1$122
Abiomed1$71
Livanova USA, Inc.1$54

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,905 in reported general payments places this provider in the 35th percentile of 546 thoracic surgery (cardiothoracic vascular surgery) providers in California.

See all thoracic surgery (cardiothoracic vascular surgery) providers in California

Medicare billing

Part B allowed, 2024
$199,551
Medicare patients
68
Services billed
450

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Palo Alto

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →